LRS
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study With QR-504a to Evaluate Safety, Tolerability & Corneal Endothelium Molecular Biomarker(s) in Subjects With FECD3 (NCT05052554) | ProQR Therapeutics | 2021-08-10 |
Track LRS automatically
Every clearance here is in the API, with alerts when new ones post.